|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.05 USD | -6.02% |
|
+7.32% | -12.37% |
| 03-11 | Legend Biotech Shares Likely to Rebound in 2026 on Robust Fundamentals, RBC Says | MT |
| 03-11 | RBC Cuts Price Target on Legend Biotech to $62 From $66, Keeps Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.52B | - | ||||
| 43.46B | |||||
| 39.86B | |||||
| 30.07B | - | ||||
| 21.62B | - | ||||
| 18.57B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition